Urol. praxi, 2011; 12(4): 246-247

Restless legs syndrome and erectile dysfunction

prof.MUDr.RNDr.Luboslav Stárka, DrSc.
Endokrinologický ústav, Praha

Restless legs syndrome (RLS) is a common somatosensoric disorder but it is uncommonly recognized and treated despite it is more

frequent than epilepsy. Its prevalence has been estimated at about 5–15 % in adult population. It is a cause of tremendous distress and

affects the quality of life of those afflicted. RLS is yet not well understood in terms of its pathophysiology, however, newer studies have

implicated dopaminergic systems and brain iron metabolism in central nervous system as an significant factor in the development of

sensomotoric disturbances. Dopmaniergic system plays a role in the mechanism of erection. It was found that men suffering from restless

legs syndrome complain on erectile dysfunction nearly twice more frequently than controls.

Keywords: restless legs syndrome, erectile dysfunction, dopamin, prevalence

Published: August 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárka L. Restless legs syndrome and erectile dysfunction. Urol. praxi. 2011;12(4):246-247.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ; International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007; 8(5): 520-530. Go to original source... Go to PubMed...
    2. Ghorayeb I, Tison F. Epidemiology of restless legs syndrome. Rev Neurol (Paris) 2009; 165(8-9): 641-649. Go to original source... Go to PubMed...
    3. Chokroverty S. Overview of sleep & sleep disorders. Indian J Med Res 2010; 131: 126-140.
    4. Natarajan R. Review of periodic limb movement and restless leg syndrome. J Postgrad Med 2010; 56: 157-162. Go to original source... Go to PubMed...
    5. Symvoulakis E, Anyfantakis D, Lionis C. Restless legs syndrome: Literature review. Sao Paulo Med. J. 2010; 128: 167-170. Go to original source... Go to PubMed...
    6. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010; 6(6): 337-346. Go to original source... Go to PubMed...
    7. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119. Go to original source... Go to PubMed...
    8. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164(2): 196-202. Go to original source... Go to PubMed...
    9. Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S, Budai R. Restless legs syndrome in end-stage renal disease. Sleep Med 2004; 5(3): 309-315. Go to original source... Go to PubMed...
    10. Gao X, Schwarzschild MA, O'Reilly EJ, Wang H, Ascherio A. Restless legs syndrome and Parkinson's disease in men. Mov Disord 2010; 25(15): 2654-2657. Go to original source... Go to PubMed...
    11. Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology. 2009; 72(14): 1255-1261. Go to original source... Go to PubMed...
    12. Monaca C. Pathophysiology of restless legs syndrome. Presse Med 2010; 39(5): 587-591. Go to original source... Go to PubMed...
    13. Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007; 369: 512-525. Go to original source... Go to PubMed...
    14. Pohanka M, Kanovsky P, Bares M, Pulkrabek J, Rektor I. Pergolide mesylate can improve sexual dysfunction in patients with Parkinson´s disease: the results of an open, prospective, 6-month follow-up. Eur J Neurol 2004? 11: 483-488. Go to original source... Go to PubMed...
    15. Zámečník L. Erektilní dysfunkce. Postgrad Med 2008; 10: 383-390.
    16. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001; 16: 1159-1163. Go to original source... Go to PubMed...
    17. Gao X, Schwarzschild MA, O'Reilly EJ, Wang H, Ascherio A. Restless legs syndrome and erectile dysfunction. Sleep 2010; 33(1): 75-79. Go to original source... Go to PubMed...
    18. Winkelmann J, Schormair B, Lichtner P, et al. Genomewide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000-1006. Go to original source... Go to PubMed...
    19. Pohanka M, Kaňovský, P. Obstrukční spánková apnoe a erektilní dysfunkce. Vnit Lék 2005? 51(5): 578-582.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.